Zobrazeno 1 - 10
of 14
pro vyhledávání: '"MTTP, Microsomal triglyceride transfer protein"'
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 745-757 (2019)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH. Although silibinin is used for the treatment of NASH in clinical, its effect on CFLAR-JNK pathway in NASH remains unclear.
Autor:
Roman Tyshynsky, Shailendra B. Patel, Sithara Raju Ponny, Kirthi Pulakanti, Babu Nageswararao Kanuri, Ranjuna Weerasekera, Kriya S. Patel, Vincent Fong
Publikováno v:
Journal of Lipid Research
Journal of Lipid Research, Vol 62, Iss, Pp 100028-(2021)
Journal of Lipid Research, Vol 62, Iss, Pp 100028-(2021)
The enzyme 3β-hydroxysterol-Δ24 reductase (DHCR24, EC 1.3.1.72) catalyzes the conversion of desmosterol to cholesterol and is obligatory for post-squalene cholesterol synthesis. Genetic loss of this enzyme results in desmosterolosis (MIM #602398),
Autor:
Emile Levy, Nickolas Auclair, Lena Ahmarani, Jean-François Beaulieu, Noël Peretti, Nathalie Patey, Schohraya Spahis, Alain T. Sané
Publikováno v:
Journal of Lipid Research
Journal of Lipid Research, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, Vol 62, Iss, Pp 100085-(2021)
Journal of Lipid Research, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2021, 62, pp.100085. ⟨10.1016/j.jlr.2021.100085⟩
Journal of Lipid Research, Vol 62, Iss, Pp 100085-(2021)
International audience; Chylomicron retention disease (CRD) is an autosomal recessive disorder associated with biallelic Sar1b mutations leading to defects in intracellular chylomicron (CM) trafficking and secretion. To date, a direct cause-effect re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437c6d76490d2b00b616f9ab5275cf52
https://doi.org/10.1016/j.jlr.2021.100085
https://doi.org/10.1016/j.jlr.2021.100085
Autor:
Steven J. Fliesler, Sriganesh Ramachandra Rao, Sithara Raju Ponny, Ned A. Porter, Shailendra B. Patel, Vincent Fong, Babu Nageswararao Kanuri, Keri A. Tallman
Publikováno v:
Journal of Lipid Research, Vol 62, Iss, Pp 100002-(2021)
Journal of Lipid Research
Journal of Lipid Research
Smith-Lemli-Opitz Syndrome (SLOS) is a developmental disorder (OMIM #270400) caused by autosomal recessive mutations in the Dhcr7 gene, which encodes the enzyme 3β-hydroxysterol-Δ7 reductase. SLOS patients present clinically with dysmorphology and
Autor:
Jennifer E. Gallagher, Dorothy Kisielewski, John F. Dillon, Shaun V. Walsh, Diane Cassidy, David J. Harrison, Ritu Sharma, Tadashi Honda, John D. Hayes, Alison D. McNeilly, Michael L.J. Ashford, Albena T. Dinkova-Kostova, Rory J. McCrimmon
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 5, Iss 3, Pp 367-398 (2018)
Cellular and Molecular Gastroenterology and Hepatology, Vol 5, Iss 3, Pp 367-398 (2018)
Background & Aims Nonalcoholic steatohepatitis (NASH) is associated with oxidative stress. We surmised that pharmacologic activation of NF-E2 p45-related factor 2 (Nrf2) using the acetylenic tricyclic bis(cyano enone) TBE-31 would suppress NASH becau
Autor:
Amalia Gastaldelli, Stefano Gatti, Miriam Longo, Stefano Romeo, Melania Gaggini, Paola Dongiovanni, Sara Badiali, Nicholas O. Davidson, Anna Ludovica Fracanzani, Guido Baselli, Serena Pelusi, Raffaela Rametta, Marica Meroni, Fabrizia Carli, Luca Valenti, Marco Maggioni
Publikováno v:
EBioMedicine
EBioMedicine, Vol 52, Iss, Pp-(2020)
EBioMedicine, Vol 52, Iss, Pp-(2020)
Background: Naturally occurring variation in Membrane-bound O-acyltransferase domain-containing 7 (MBOAT7), encoding for an enzyme involved in phosphatidylinositol acyl-chain remodelling, has been associated with fatty liver and hepatic disorders. He
Autor:
Luca Miele, Erika Paolini, Miriam Longo, Valentina D'Oria, Annalisa Crudele, Marco Maggioni, Luca Valenti, Marica Meroni, Paola Dongiovanni, Emanuele Bellacchio, Anna Alisi, Nadia Panera, Anna Ludovica Fracanzani
Publikováno v:
EBioMedicine
EBioMedicine, Vol 65, Iss, Pp 103249-(2021)
EBioMedicine, Vol 65, Iss, Pp 103249-(2021)
Background The rs17618244 G>A β-Klotho (KLB) variant has been associated with increased risk of ballooning and inflammation in pediatric patients with metabolic associated fatty liver disease (MAFLD), by reducing KLB expression. In hepatocytes, KLB
Autor:
Ching-Shu Suen, Chih-Syuan Liu, Ming-Jing Hwang, Hubert W Peng, Hsin-Chou Yang, Chia-Jen Lee, Tzu-Yuan Chiu, Yu-Jen Liang, Hsin-Fang Yang-Yen, Hung-Ta Chen, Jeffrey J.Y. Yen, M. Mahmood Hussain
Publikováno v:
The Journal of Biological Chemistry
Microsomal triglyceride transfer protein (MTTP) is an endoplasmic reticulum resident protein that is essential for the assembly and secretion of triglyceride (TG)-rich, apoB-containing lipoproteins. Although the function and structure of mammalian MT
Autor:
Takahiro Yamaura, Frank J. Gonzalez, Tadanobu Nagaya, Toshifumi Aoyama, Takefumi Kimura, Naoki Tanaka, Hiroyuki Kitabatake, Kenji Sano, Michiharu Komatsu, Naoyuki Fujimori, Eiji Tanaka, Takeji Umemura, Akira Horiuchi
Publikováno v:
BBA Clinical
Background and aim It is recognized that nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), may develop after pancreaticoduodenectomy (PD). However, the mechanism of NASH development remains unclear. This study a
Autor:
Michael Trauner, Hanns-Ulrich Marschall, Curt Einarsson, Anders Thorell, Tatjana Stojakovic, Pooja Jha, Guenter Fauler, Thierry Claudel, Bastian Hoesel, Michaela Mueller, Harald Koefeler, Carolin Lackner
Publikováno v:
Journal of Hepatology
Graphical abstract
Background & Aims Bile acids (BAs) are major regulators of hepatic BA and lipid metabolism but their mechanisms of action in non-alcoholic fatty liver disease (NAFLD) are still poorly understood. Here we aimed to explore the m
Background & Aims Bile acids (BAs) are major regulators of hepatic BA and lipid metabolism but their mechanisms of action in non-alcoholic fatty liver disease (NAFLD) are still poorly understood. Here we aimed to explore the m